Hepatobiliary Pancreat Dis Int  2022, Vol. 21 Issue (6): 605-608 DOI: 10.1016/j.hbpd.2022.06.010 |
|
|||
| Safety and immunogenicity of COVID-19 vaccination among liver transplant recipients in China | |||
| Qiu-Ju Tian a , b , # , Man Xie c , # , Ji-Tao Wang d , # , Yi Wang e , Bei Zhang f , Jin-Zhen Cai a , b , Xiao-Long Qi g , Wei Rao a , b , ∗ | |||
| a Division of Hepatology, Liver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao 266000, China b Department of Organ Transplantation, The Affiliated Hospital of Qingdao University, Qingdao 266000, China c Department of Gastroenterology, The Affiliated Hospital of Qingdao University, Qingdao 266000, China d CHESS-COVID-19 Group, Xingtai People’s Hospital, Xingtai 054000, China e Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao 266000, China f Department of Immunology, Qingdao University Medical College, Qingdao 266000, China g CHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou 730000, China ∗ Corresponding author at: Division of Hepatology, Liver Disease Center, Department of Organ Transplantation, the Affiliated Hospital of Qingdao University, No. 59 Hai’er Road, Laoshan District, Qingdao 266000, China. E-mail address: qdfy_raowei@126.com (W. Rao). # Contributed equally. |
|||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
